Daniel C. Allen

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Daniel C. Allen

Daniel C. Allen was last confirmed as Board Member at PharmaCyte Biotech, Inc. (PMCB) in a filing dated November 25, 2022. PharmaCyte Biotech, Inc. reported in an 8-K filed August 16, 2022 that Daniel C. Allen was appointed independent director.

“Jack E. Stover, Daniel S. Farb, and Daniel C. Allen will also join PharmaCyte's reconstituted Board as independent directors.”

PharmaCyte Biotech, Inc. Form 8-K, filed August 16, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Daniel C. Allen's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

PharmaCyte Biotech, Inc. (PMCB)
Board Member

Proxy statement

Start not stated–2022-11-25

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

PharmaCyte Biotech, Inc.

PMCB

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: independent director PharmaCyte Biotech, Inc. (PMCB)
2022-08-16